195 related articles for article (PubMed ID: 38023992)
1. Coronavirus disease 2019 and lung cancer: where are we?
Ocanto A; Mielgo-Rubio X; Luna Tirado J; Linares Mesa N; López Valcárcel M; Pedraza S; Barragan VV; Nieto PV; Martín JZ; Couñago F
Explor Target Antitumor Ther; 2023; 4(5):1082-1094. PubMed ID: 38023992
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
Mokos M; Bašić-Jukić N
Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
6. Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group.
Baldotto C; Gelatti A; Accioly A; Mathias C; Mascarenhas E; Carvalho H; Faroni L; Araújo LH; Zukin M; Gadia R; Terra RM; Haddad R; Lima VC; Castro-Júnior G
Clinics (Sao Paulo); 2020; 75():e2060. PubMed ID: 32578829
[TBL] [Abstract][Full Text] [Related]
7. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
8. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
9. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
10. CO RADS grade of HRCT Thorax and RT PCR testing for the diagnosis of coronavirus disease 2019 (COVID 19): A descriptive hospital based study of asymptomatic planned surgery cases.
Ghosh K; Ghosh S; Acharyya A; Sarkar K; Bhattacharya A; Hassan MS; Ghosh US
Ann Afr Med; 2023; 22(1):40-44. PubMed ID: 36695220
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids for the treatment of COVID-19.
Griesel M; Wagner C; Mikolajewska A; Stegemann M; Fichtner F; Metzendorf MI; Nair AA; Daniel J; Fischer AL; Skoetz N
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD015125. PubMed ID: 35262185
[TBL] [Abstract][Full Text] [Related]
12. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
13. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
14. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
15. Chest CT in the Emergency Department for Diagnosis of COVID-19 Pneumonia: Dutch Experience.
Schalekamp S; Bleeker-Rovers CP; Beenen LFM; Quarles van Ufford HME; Gietema HA; Stöger JL; Harris V; Reijers MHE; Rahamat-Langendoen J; Korevaar DA; Smits LP; Korteweg C; van Rees Vellinga TFD; Vermaat M; Stassen PM; Scheper H; Wijnakker R; Borm FJ; Dofferhoff ASM; Prokop M
Radiology; 2021 Feb; 298(2):E98-E106. PubMed ID: 33201791
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study.
Guarneri V; Bassan F; Zagonel V; Milella M; Zaninelli M; Cattelan AM; Vianello A; Gori S; Aprile G; Azzarello G; Chiari R; Favaretto A; Oliani C; Scola A; Pastorelli D; Mandarà M; Zustovich F; Bernardi D; Chiarion-Sileni V; Morandi P; Toso S; Di Liso E; Ziampiri S; Caccese M; Zampiva I; Puccetti O; Celestino M; Dieci MV; Conte P;
Eur J Cancer; 2021 Apr; 147():120-127. PubMed ID: 33647547
[TBL] [Abstract][Full Text] [Related]
18. Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic.
Kumar S; Chmura S; Robinson C; Lin SH; Gadgeel SM; Donington J; Feliciano J; Stinchcombe TE; Werner-Wasik M; Edelman MJ; Moghanaki D
J Thorac Oncol; 2020 Jul; 15(7):1137-1146. PubMed ID: 32360578
[TBL] [Abstract][Full Text] [Related]
19. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
20. Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.
Tamura T; Ninomiya K; Kubo T; Kuyama S; Tachibana S; Inoue K; Chikamori K; Kudo K; Ochi N; Harada D; Maeda Y; Kiura K
Thorac Cancer; 2022 Feb; 13(3):453-459. PubMed ID: 34964270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
